Specialist Doctors Launch Sapphire Medical Clinic, UK's First Medicinal Cannabis Clinic to Treat Full Range of Health Issues Including Childhood Epilepsy
LONDON, July 24, 2019 /PRNewswire/ -- A group of leading doctors have today launched Sapphire Medical Clinic in London, the first clinic in the UK which can offer access to medicinal cannabis for all conditions acknowledged to benefit from it and to do so as part of a comprehensive treatment pathway, including other conventional pharmaceutical drugs and treatments.
Dr Mikael Sodergren, Managing Director and Academic Lead at Sapphire Medical Clinics said:
"Medicinal cannabis is a new and exciting field. But it is important that access to it is delivered in a way that fits in with other treatment options. Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. We have the expertise to prescribe medicinal cannabis in a way that fits in with other more conventional treatments as and when we judge that to be in the best interest of the patients. Our service to patients will work on the basis of 'we are specialists in your condition, and our aim is to help you get better which may, or may not, involve medical cannabis, which we have the expertise to prescribe', rather than 'come to us to try medical cannabis'. Operating in this way means that doctors can have the confidence to refer their patients to us, and patients can have the confidence that we will prescribe medicinal cannabis in a way that fits in with other treatments."
Sapphire is fully controlled by the founding doctors and therefore the clinicians have complete freedom to prescribe any range of medicinal cannabis products from any available supplier.
The Sapphire team have also announced that they will build the first UK wide national database recording how patients react to medicinal cannabis.
Dr Sodergren added:
"The medical world needs more evidence about the efficacy of medicinal cannabis and our national database will be a major contribution to meet that need. It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway."
The Sapphire doctors are all highly qualified specialists in their respective fields and include world leading experts such as pain specialist Dr Michael Platt, who frequently treats complex patients referred from the UK and abroad. In addition, the Sapphire team includes specialists in paediatric & adult neurology, palliative care, psychiatry, gastroenterology, acute general medicine and neuropathic pain, and can replicate the multi-disciplinary approach championed by the MHRA and NHS England as the safe and proper way to consider medicinal cannabis prescriptions.